# Coated Aldehyde Oxystarch for Protein-Bound Uremic Toxin Reduction in End-Stage Renal Disease

> **NCT07653711** · NA · RECRUITING · sponsor: **Peking University People's Hospital** · enrollment: 30 (estimated)

## Conditions studied

- End Stage Renal Disease on Dialysis

## Interventions

- **DRUG:** Coated Aldehyde Oxystarch

## Key facts

- **NCT ID:** NCT07653711
- **Lead sponsor:** Peking University People's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-04-21
- **Primary completion:** 2026-07
- **Final completion:** 2026-08
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2026-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07653711

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07653711, "Coated Aldehyde Oxystarch for Protein-Bound Uremic Toxin Reduction in End-Stage Renal Disease". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07653711. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*